Search Results for: Gene Therapy
Funding RNA Therapeutics
Replicate Bioscience Secures $40 Million in Series A to Advance RNA Therapeutics
2021-09-10
Licensing RNA Editing
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Novel Mutational Patterns Explain Evolution of Lung Cancer in Never-Smokers
2021-09-09
Trials & Approvals CAR T-cell Therapy
JW Therapeutics’ CAR-T Approval in China Comes On the Heels of its Rival
2021-09-08
Licensing
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Special Gene Editing
Researchers Engineer “Mini” CRISPR-Cas System That Could Act as ‘Swiss Army Knife’ for Mammalian Genome Editing
2021-09-07
Trials & Approvals Gene Therapy
Cancer Fears Puts BioMarin’s Phearless Study on Hold
2021-09-07
Trials & Approvals FDA Approval
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Trials & Approvals Gene Therapy
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
Trials & Approvals Schizophrenia
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
Asia-Pacific
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Trials & Approvals Aduhelm
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
China
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
Technology Targeted Protein Degrader
Eli Lilly, Lycia Partnership Signifies the Growing Targeted Protein Degradation Market
2021-08-27
1 … 54 55 56 57 58 … 105
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top